ATAI Life Sciences N.V.
Find Ratings ReportsATAI LIFE SCIENCES N V's gross profit margin for the third quarter of its fiscal year 2023 has significantly increased when compared to the same period a year ago. The company grew its sales and net income significantly quarter versus same quarter a year prior, and was able to outpace the average competitor in the subsector when comparing revenue growth, but not when comparing net income growth. ATAI LIFE SCIENCES N V is extremely liquid. Currently, the Quick Ratio is 10.69 which clearly shows the ability to cover any short-term cash needs. The company's liquidity has decreased from the same period last year.
During the same period, stockholders' equity ("net worth") has decreased by 7.99% from the same quarter last year. Overall, the key liquidity measurements indicate that the company is very unlikely to face financial difficulties in the near future.
STOCKS TO BUY: TheStreet Quant Ratings has identified a handful of stocks that can potentially TRIPLE in the next 12-months. To learn more visit www.TheStreetRatings.com.
Income Statement | Q3 FY23 | Q3 FY22 |
---|---|---|
Net Sales ($mil) | 0.09 | 0.03 |
EBITDA ($mil) | -26.75 | -38.39 |
EBIT ($mil) | -26.82 | -38.42 |
Net Income ($mil) | 44.25 | -33.89 |
Balance Sheet | Q3 FY23 | Q3 FY22 |
---|---|---|
Cash & Equiv. ($mil) | 208.99 | 304.06 |
Total Assets ($mil) | 308.22 | 342.6 |
Total Debt ($mil) | 16.67 | 15.0 |
Equity ($mil) | 266.28 | 289.4 |
Profitability | Q3 FY23 | Q3 FY22 |
---|---|---|
Gross Profit Margin | -30743.68 | -153548.0 |
EBITDA Margin | -30743.67 | -153548.0 |
Operating Margin | -30828.74 | -153692.0 |
Sales Turnover | 0.0 | 0.0 |
Return on Assets | -21.71 | -57.28 |
Return on Equity | -25.14 | -67.81 |
Debt | Q3 FY23 | Q3 FY22 |
---|---|---|
Current Ratio | 10.96 | 12.25 |
Debt/Capital | 0.06 | 0.05 |
Interest Expense | 0.69 | 0.0 |
Interest Coverage | -39.15 | 0.0 |
Share Data | Q3 FY23 | Q3 FY22 |
---|---|---|
Shares outstanding (mil) | 166.01 | 165.88 |
Div / share | 0.0 | 0.0 |
EPS | 0.25 | -0.22 |
Book value / share | 1.6 | 1.74 |
Institutional Own % | n/a | n/a |
Avg Daily Volume | 1501773.0 | 686036.0 |
SELL. The current P/E ratio is negative, which has no meaningful value in the assessment of premium or discount valuation, it simply displays that the company has negative earnings. For additional comparison, its price-to-book ratio of 1.05 indicates a significant discount versus the S&P 500 average of 4.68 and a significant discount versus the subsector average of 19.07. The price-to-sales ratio is well above both the S&P 500 average and the subsector average, indicating a premium. The valuation analysis reveals that, ATAI LIFE SCIENCES N V seems to be trading at a premium to investment alternatives.
Price/Earnings |
|
Price/Cash Flow |
| |||||||||||||||||||||
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
ATAI NM | Peers 85.83 | ATAI NM | Peers 38.76 | |||||||||||||||||||||
Neutral. The absence of a valid P/E ratio happens when a stock can not be valued on the basis of a negative stream of earnings. ATAI's P/E is negative making this valuation measure meaningless. |
Neutral. The P/CF ratio, a stock’s price divided by the company's cash flow from operations, is useful for comparing companies with different capital requirements or financing structures. ATAI's P/CF is negative making the measure meaningless. |
|||||||||||||||||||||||
Price/Projected Earnings |
|
Price to Earnings/Growth |
|
|||||||||||||||||||||
ATAI NM | Peers 18.08 | ATAI NA | Peers 1.16 | |||||||||||||||||||||
Neutral. The absence of a valid price-to-projected earnings ratio happens when a stock can not be valued on the basis of a negative expected future earnings. ATAI's ratio is negative making this valuation measure meaningless. |
Neutral. The PEG ratio is the stock’s P/E divided by the consensus estimate of long-term earnings growth. Faster growth can justify higher price multiples. Ratio not available. |
|||||||||||||||||||||||
Price/Book |
|
Earnings Growth |
|
|||||||||||||||||||||
ATAI 1.05 | Peers 19.07 | ATAI 65.12 | Peers 12.58 | |||||||||||||||||||||
Discount. A lower price-to-book ratio makes a stock more attractive to investors seeking stocks with lower market values per dollar of equity on the balance sheet. ATAI is trading at a significant discount to its peers. |
Higher. Elevated earnings growth rates can lead to capital appreciation and justify higher price-to-earnings ratios. ATAI is expected to have an earnings growth rate that significantly exceeds its peers. |
|||||||||||||||||||||||
Price/Sales |
|
Sales Growth |
|
|||||||||||||||||||||
ATAI 845.14 | Peers 84.44 | ATAI -21.42 | Peers 42.35 | |||||||||||||||||||||
Premium. In the absence of P/E and P/B multiples, the price-to-sales ratio can display the value investors are placing on each dollar of sales. ATAI is trading at a significant premium to its subsector. |
Lower. A sales growth rate that trails the subsector implies that a company is losing market share. ATAI significantly trails its peers on the basis of sales growth. |
|||||||||||||||||||||||